Home Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
Article Open Access

Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V

  • Heng-Qiang Zhang ORCID logo , Xia Juan , Xu Ning , Fu-Jian Fang , Xin Yang and Xiu-Jun Zheng EMAIL logo
Published/Copyright: March 23, 2022
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 237 Issue 3

Abstract

C3H10N3O5V, monoclinic, P21/c (no. 14), a = 5.487(2) Å, b = 7.611(3) Å, c = 19.629(8) Å, β = 101.269(11)°, V = 803.9(5) Å3, Z = 4, R gt (F) = 0.0375, wRref(F2) = 0.0866, T = 293(2) K.

CCDC no.: 2158294

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colorless block
Size: 0.20 × 0.18 × 0.16 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 1.23 mm−1
Diffractometer, scan mode: Xcalibur, φ and ω
θmax, completeness: 27.7°, 99%
N(hkl)measured, N(hkl)unique, Rint: 5226, 1886, 0.036
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 1413
N(param)refined: 136
Programs: Bruker [1], SHELX [2], WinGX/ORTEP [3], PLATON [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
V1 0.61055 (8) 0.56706 (6) 0.82000 (2) 0.02664 (14)
O1 0.7704 (3) 0.6556 (3) 0.74914 (10) 0.0350 (5)
O2 0.5665 (3) 0.7983 (3) 0.85368 (9) 0.0337 (5)
O3 0.3389 (3) 0.5270 (3) 0.77583 (10) 0.0365 (5)
O4 0.9655 (3) 0.5606 (3) 0.89033 (9) 0.0320 (4)
O5 1.2450 (4) 0.4009 (3) 0.96115 (11) 0.0468 (6)
N1 0.8063 (4) 0.4736 (3) 0.75089 (12) 0.0317 (5)
H1A 0.959260 0.434566 0.767578 0.038*
H1B 0.723658 0.411610 0.715312 0.038*
N2 0.4977 (4) 0.6800 (3) 0.90072 (11) 0.0323 (5)
H2A 0.336702 0.672726 0.901933 0.039*
H2B 0.597866 0.670738 0.942087 0.039*
N3 0.6189 (5) 0.3185 (4) 0.87021 (15) 0.0359 (6)
H3Aa 0.536517 0.326349 0.904912 0.043*
H3Ba 0.541288 0.239746 0.840061 0.043*
H3Ib 0.488 (12) 0.333 (8) 0.895 (3) 0.043*
H3Jb 0.597 (13) 0.252 (10) 0.846 (4) 0.043*
C1 1.0378 (5) 0.4196 (4) 0.92227 (14) 0.0357 (7)
C2a 0.8744 (16) 0.2564 (13) 0.8980 (5) 0.035 (2)
H2Ca 0.937856 0.201243 0.859828 0.042*
C3a 0.8743 (18) 0.1204 (10) 0.9533 (4) 0.072 (3)
H3Ca 0.768939 0.024326 0.934521 0.108*
H3Da 0.813440 0.171637 0.991423 0.108*
H3Ea 1.040522 0.078215 0.969320 0.108*
C2Bb 0.8508 (14) 0.2700 (11) 0.9214 (4) 0.028 (2)
H2Db 0.817806 0.244313 0.967643 0.034*
C3Bb 0.9760 (12) 0.1170 (9) 0.8915 (4) 0.051 (2)
H3Fb 0.872578 0.014535 0.889057 0.076*
H3Gb 1.133923 0.093329 0.920991 0.076*
H3Hb 1.000302 0.146827 0.845822 0.076*

  1. aOccupancy: 0.484 (9), bOccupancy: 0.516 (9).

Source of material

All reagents were obtained from commercial sources and used without further purification. The compound was synthesized by aqueous reactions: NH4VO3 (1.72 mmol), alanine (5.00 mmol) and NaOH (6.61 mmol) was dissolved in 12 mL of aqueous solution at room temperature. The resulting yellow solution was cooled to 275 K in an ice bath. NH2OH…HCl (4.31 mmol) was added slowly with constant stirring. The pH of the solution was about 6.5. The obtained yellow solution was filtered. Colorless crystals were obtained by slow evaporation of the filtrate from ethanol at 277 K for a few days. Anal. Calcd. for C3H10N3O5V (%): C, 16.45; H, 4.60; N, 19.18; V, 23.25. Found: C, 16.51; H, 4.56; N, 19.20; V, 23.22. The vanadium content was determined by spectrophotometry.

Experimental details

The structure was solved by direct methods with the SHELXS-2018 program [2]. The H atoms bonded to N3 atoms were located in difference maps and refined freely. Other H atoms were placed in calculated positions. The Carbon atoms C2 and C3 are disordered over two positions.

Comment

Vanadium is a trace element in biochemical systems to play an important role in metalloenzymes and impact insulin regulation [5]. In recent years, a number of vanadium hydroxylamido complexes have shown that the hydroxylamido ligand coordinates in a side-on manner as does the peroxo functionality [6]. To the best of our knowledge, the coordination chemistry of vanadium hydroxylamine complexes has been less studied so far [7], [8], [9]. Therefore, we have synthesized the title compound, and report crystal structure.

In the crystal structure of the title compound the vanadium(V) centers are seven-coordinated in pentagonal bipyramidal geometry containing two bidentate hydroxylamido ligands, one oxido, and one alaninato ligand. The two hydroxylamine molecules and the amine nitrogen atom of alanine molecule define a pentagonal equatorial plane approximately perpendicular to V=O bond, while the two oxygen atoms [O3, O4] occupy the axial position, and the distance of vanadium from the equatorial plane is 0.238 Å. The hydroxylamido ligands are coordinated with the nitrogen atoms cis to the alaninato ligand. The carboxylate oxygen atom of alanine is coordinated trans to the oxido group in the complex, the V–N bond lengths are 2.018(2) and 2.004(2) Å, respectively, and the V–O bond lengths are 1.906(2) and 1.912(2) Å, respectively. The molecular structure of the compound is very similar to the other vanadium(V) hydroxylamido complexes with amino acid ligands [10, 11].

Corresponding author: Xiu-Jun Zheng, Department of Chemical Engineering, Harbin Institute of Petroleum, Harbin 150027, People’s Republic of China, E-mail:

Funding source: Natural Science Foundation of Heilongjiang Province of China

Award Identifier / Grant number: LH2019B029

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was financially supported by the Department of Science and Technology of Natural Science Foundation of Heilongjiang Province of China (LH2019B029).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. BRUKER. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2008.Search in Google Scholar

2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

3. Farrugia, L. J. WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.Search in Google Scholar

4. Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. 2009, D65, 148–155; https://doi.org/10.1107/s090744490804362x.Search in Google Scholar

5. Crans, D. C., Smee, J. J., Gaidamauskas, E., Yang, L. Q. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem. Rev. 2004, 104, 849–902; https://doi.org/10.1021/cr020607t.Search in Google Scholar

6. Smee, J. J., Epps, J. A., Ooms, K., Bolte, S. E., Polenova, T., Baruah, B., Yang, L. Q., Ding, W. J., Li, M., Willsky, G. R., la Cour, A., Anderson, O. P., Crans, D. C. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties. J. Inorg. Biochem. 2009, 103, 575–584; https://doi.org/10.1016/j.jinorgbio.2008.12.015.Search in Google Scholar

7. Arrambide, G., Gambino, D., Baran, E. Synthesis and spectroscopic characterization of hydroxylamido/amino acid complexes of oxovanadium(V). J. Coord. Chem. 2009, 62, 63–74; https://doi.org/10.1080/00958970802474821.Search in Google Scholar

8. Crans, D. C., Smee, J. J., Gaidamauskiene, E. G., Anderson, O. P., Miller, S. M., Jin, W. Z., Gaidamauskas, E., Crubellier, E., Grainda, R., Chi, L. H., Willsky, G. R. Inhibition of yeast growth by molybdenum-hydroxylamido complexes correlates with their presence in media at differing pH values. J. Inorg. Biochem. 2004, 98, 1837–1850; https://doi.org/10.1016/j.jinorgbio.2004.08.010.Search in Google Scholar

9. Keramidas, A. D., Miller, S. M., Anderson, O. P., Crans, D. C. Vanadium(V) hydroxylamido complexes: solid state and solution properties. J. Am. Chem. Soc. 1997, 119, 8901–8915; https://doi.org/10.1021/ja970747y.Search in Google Scholar

10. Zhang, H. Q., Zhang, Q. Y., Li, J., Liu, D., Wu, X. F., Shan, Y. K. Synthesis, characterization and PTP1B inhibitory activity of the vanadium complexes with amino-acids. Chem. J. Chin. Univ. 2012, 33, 243–250.Search in Google Scholar

11. Li, L. Z., Xu, T., Wang, D. Q. Synthesis and crystal structure of two vanadium(V) hydroxylamido complexes with amino acid ligands. J. Chem. Crystallogr. 2004, 34, 585–590; https://doi.org/10.1023/b:jocc.0000044084.32526.8d.10.1023/B:JOCC.0000044084.32526.8dSearch in Google Scholar
Received: 2022-02-14
Accepted: 2022-03-14
Published Online: 2022-03-23
Published in Print: 2022-06-27

© 2022 Heng-Qiang Zhang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
  4. Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
  5. Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
  6. The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
  7. Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
  8. Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
  9. Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
  10. Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
  11. The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  12. Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
  13. Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
  14. The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
  15. Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
  16. Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
  17. The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
  18. Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
  19. The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
  20. The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
  21. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
  22. The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
  23. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
  24. Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
  25. The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
  26. Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
  27. Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
  28. Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
  29. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
  30. The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
  31. The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
  32. The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
  33. The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
  34. Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
  35. The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
  36. Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
  37. Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
  38. Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
  39. The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
  40. Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
  41. Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
  42. Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
  43. Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
  44. The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
  45. The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
  46. Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
  47. The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
  48. Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
https://doi.org/10.1515/ncrs-2022-0071
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
  4. Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
  5. Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
  6. The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
  7. Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
  8. Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
  9. Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
  10. Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
  11. The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  12. Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
  13. Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
  14. The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
  15. Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
  16. Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
  17. The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
  18. Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
  19. The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
  20. The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
  21. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
  22. The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
  23. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
  24. Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
  25. The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
  26. Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
  27. Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
  28. Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
  29. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
  30. The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
  31. The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
  32. The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
  33. The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
  34. Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
  35. The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
  36. Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
  37. Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
  38. Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
  39. The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
  40. Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
  41. Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
  42. Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
  43. Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
  44. The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
  45. The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
  46. Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
  47. The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
  48. Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0071/html
Scroll to top button